ARCHIVES

New Immunotherapy Increased Survival Of Neuroblastoma In Phase III Trial

This article is from The Cancer Letter archive.

Vol. 33 No. 9 | September 24, 2010

Download PDF Visit The Full Archive

Related Articles

HHS Group To Study Policies Affecting Academic Centers

June 20, 1997

Ibrutinib Shows Disease Control In Elderly, High-Risk CLL Patients

April 26, 2013

Anti-Impoundment, Panel Stay In Cancer Renewal Act; Conferees Finally Agree On Research Training Bill

June 14, 1974

AACR Urges FDA To Speed Approval of Therapies for Precancerous Lesions

November 15, 2002

Obituaries: Sylvan Green, Donald Gleason

January 23, 2009

St. Jude Considers Relocating to Washington U.

August 9, 1985